Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective

Affiliations

Ennio Lubrano: Head of Academic Rheumatology Unit and MoRhe Project, Dipartimento di Medicina e Scienze Della Salute “Vincenzo Tiberio”, Università Degli Studi del Molise
Silvia Scriffignano: Head of Academic Rheumatology Unit and MoRhe Project, Dipartimento di Medicina e Scienze Della Salute “Vincenzo Tiberio”, Università Degli Studi del Molise
Fabio Massimo Perrotta: Head of Academic Rheumatology Unit and MoRhe Project, Dipartimento di Medicina e Scienze Della Salute “Vincenzo Tiberio”, Università Degli Studi del Molise

Abstract

No abstracts available.

ISSN: 2198-6576 (Print); 2198-6584 (Online)
Publisher: Adis, Springer Healthcare
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the musculoskeletal system
Website: https://www.springer.com/journal/40744